Francesco Raspagliesi
Charité
CancerRadiologySurgeryOncologyRetrospective cohort studySentinel nodeProspective cohort studyHazard ratioChemotherapyRadical surgeryEndometrial cancerCervical cancerDiseaseHysterectomyOvarian cancerLymphadenectomyLymph nodeRadical HysterectomyGynecologyMedicine
403Publications
43H-index
7,774Citations
Publications 408
Newest
#1Giorgio BoganiH-Index: 27
Last. Francesco RaspagliesiH-Index: 43
view all 68 authors...
OBJECTIVE To evaluate the outcomes of high-risk (HR) HPV-positive and -negative women affected by high-grade cervical dysplasia. METHODS This is a retrospective multi-institutional study. Medical records of consecutive patients with high-grade cervical dysplasia undergoing conization between 2010 and 2014 were retrieved. All patients included had at least 5 years of follow-up. A propensity-score matching was adopted in order to reduce the presence of confounding factors between groups. Kaplan-Me...
1 CitationsSource
#1Francesca Filippi (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)H-Index: 5
#2Fabio MartinelliH-Index: 20
Last. Valentina ChiappaH-Index: 15
view all 6 authors...
Source
#1Elmar A. Joura (Medical University of Vienna)H-Index: 26
#2Angels UliedH-Index: 2
Last. Frederick Wittke (MSD: Merck & Co.)
view all 27 authors...
Abstract Background Efficacy of the nine-valent human papillomavirus (9vHPV; HPV types 6/11/16/18/31/33/45/52/58) vaccine was demonstrated in a phase 3 study in women 16–26 years of age. We present a phase 3 immunogenicity and safety study of the 9vHPV vaccine in women 27–45 versus 16–26 years of age. Methods This international, open-label study (NCT03158220) was conducted in women 16–45 years of age. Participants (16–26 years, n = 570 and 27–45 years, n = 642) received a three-dose 9vHPV vaccin...
Source
#2Giorgio BoganiH-Index: 27
Last. Fabio Ghezzi (University of Insubria)H-Index: 55
view all 14 authors...
PURPOSE To investigate oncological outcomes and patterns of recurrence of patients undergoing adjuvant "sandwich" chemo-radio-chemotherapy for locally advanced endometrial cancer. METHODS This is a multi-institutional retrospective study evaluating chart of consecutive patients undergoing chemo-radio-chemotherapy for FIGO stage III-IVA endometrial caner. RESULTS The study population included 45 patients who had adjuvant sandwich regimen. Median age of the study population was 66 years. The major...
1 CitationsSource
INTRODUCTION To evaluate oncological and obstetrical outcomes of early stage cervical cancer patients who underwent conservative management to retain childbearing potential. METHODS Data of women (aged <40 years) who underwent fertility sparing treatment for International Federation of Gynecology and Obstetrics (FIGO) stage IA1 with lymphovascular invasion (LVSI) and IB1 cervical cancer were prospectively collected. All patients underwent cervical conization/s and laparoscopic nodal evaluation (...
Source
Source
#1A Ditto (DITTO)H-Index: 3
#2Jvan CasarinH-Index: 17
Last. Francesco RaspagliesiH-Index: 43
view all 20 authors...
Source
#1Sandro PignataH-Index: 50
#2Domenica LorussoH-Index: 37
Last. F Perrone
view all 64 authors...
BACKGROUND Bevacizumab is approved in combination with chemotherapy for the treatment of ovarian cancer, either in first-line therapy or for patients with recurrent disease not previously treated with the same drug. We aimed to test the value of continuing bevacizumab beyond progression after first-line treatment with the same drug. METHODS In our open-label, randomised, phase 3 trial done at 82 sites in four countries, we enrolled women (aged ≥18 years) who had previously received first-line pl...
Source
#1Juliana RodriguezH-Index: 2
#2Jose Alejandro Rauh-Hain (University of Texas MD Anderson Cancer Center)H-Index: 17
Last. Rene Pareja (UPB: Pontifical Bolivarian University)H-Index: 12
view all 24 authors...
Introduction Recent evidence has shown adverse oncological outcomes when minimally invasive surgery is used in early-stage cervical cancer. The objective of this study was to compare disease-free survival in patients that had undergone radical hysterectomy and pelvic lymphadenectomy, either by laparoscopy or laparotomy. Methods We performed a multicenter, retrospective cohort study of patients with cervical cancer stage IA1 with lymph-vascular invasion, IA2, and IB1 (FIGO 2009 classification), b...
Source
#1Giorgio BoganiH-Index: 27
#2Andrea PapadiaH-Index: 24
Last. Francesco RaspagliesiH-Index: 43
view all 29 authors...
Abstract Objective Sentinel node mapping (SLN) has replaced lymphadenectomy for staging surgery in apparent early-stage low and intermediate risk endometrial cancer (EC). Only limited data about the adoption of SNM in high risk EC is still available. Here, we evaluate the outcomes of high-risk EC undergoing SNM (with or without back-up lymphadenectomy). Methods This is a multi-institutional international retrospective study, evaluating data of high-risk (FIGO grade 3 endometrioid EC with myometr...
Source
12345678910
Close Researchers